Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


Improved efficiencies for small molecule discovery

publication date: Jun 26, 2023
author/source: Cresset
Molecular Dynamics simulation displayed in Flare V7. The GCNCMC option enables an enhanced sampling of hydration patterns in the protein active site.


Cresset, innovative provider of solutions for CADD, DMTA efficiency and contract research, releases Flare™ V7, a comprehensive drug design platform that integrates the power of ligand and structure-based methods.

New features and methods in Flare V7 include significantly enhanced Dynamics and Flare FEP calculations, a new ensemble docking method, enhanced quantitative SAR (QSAR) and Quantum Mechanics (QM) methods, and more tools to troubleshoot Flare FEP experiments, analyze dynamics trajectories, and prepare ligand structures for further studies.

“The new and enhanced methods in Flare V7 are based on our latest science and in response to feedback from our customers of the software, ensuring that we deliver what the users require to accelerate their drug discovery projects,” said Giovanna Tedesco, Head of Products, Cresset. “Developments in our underlying scientific methods deliver efficiencies and enable researchers to work collaboratively in an easy-to-use environment.”


The Flare V7 release includes:

  • Introduction of GCNCMC (Grand Canonical Nonequilibrium Candidate Monte Carlo) in Dynamics and Flare FEP calculations to improve the sampling of hydration patterns into the protein active site.
  • Merging Covalent Docking and Ensemble Docking to create the new Ensemble Covalent Docking workflow, enabling users to consider active site flexibility when generating binding poses for covalent inhibitors, by including multiple protein active site conformations within the same docking experiment.
  • Expanded choice of methods for performing QM calculations on larger ligands, through the inclusion of the computationally efficient GFN2-xTB semi-empirical method
  • Wider range of methods for building predictive QSAR models, now including Consensus regression and classification, enabling Flare to predict the activity of new compounds based on the consensus of predictions from key regression and classification models


About Cresset

Chemists in the world’s leading research organizations use Cresset solutions to discover, design, optimize, synthesize and track the best small molecules. Our patented CADD Software, collaborative Torx® DMTA design-make-test-analyze platform, and expert Discovery CRO scientists, enable chemists to enhance efficiency and win the race to scientific success in industry sectors including: pharmaceuticals, agrochemicals, fine chemicals and flavors and fragrances.


Recent news from Cresset


If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events